Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
May 21, 2021
Analysis of Myc Chromatin Binding by Calibrated ChIP-Seq Approach
Donald P Cameron, Vladislav Kuzin, Laura Baranello
STAR Protocols
|
August 9, 2022
TOP1 CAD-seq: A protocol to map catalytically engaged topoisomerase 1 in human cells
Vladislav Kuzin, Anika Wiegard, Donald P Cameron, et al.
Plos Genetics
|
September 9, 2021
Deficiency of Polη in Saccharomyces cerevisiae reveals the impact of transcription on damage-induced cohesion
Pei-Shang Wu, Jan Grosser, Donald P Cameron, et al.
Plos Pathogens
|
September 20, 2021
The Epstein-Barr virus deubiquitinating enzyme BPLF1 regulates the activity of topoisomerase II during productive infection
Jinlin Li, Noemi Nagy, Jiangnan Liu, et al.
Plos Neglected Tropical Diseases
|
March 7, 2017
Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis
Louise E Kerry, Elaine E Pegg, Donald P Cameron, et al.
Biomedicines
|
July 27, 2024
CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci
Donald P Cameron, Jirawas Sornkom, Sameerh Alsahafi, et al.
Frontiers in Cell and Developmental Biology
|
July 29, 2020
rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
Jinbae Son, Katherine M Hannan, Gretchen Poortinga, et al.
Molecular Cell
|
November 12, 2021
Topoisomerase 1 activity during mitotic transcription favors the transition from mitosis to G1
Anika Wiegard, Vladislav Kuzin, Donald P Cameron, et al.
Nature Communications
|
February 9, 2026
MYC modulates TOP2A diffusion to promote substrate detection and activity
Donald P Cameron, Kathryn Jackson, Alessia Loffreda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2016
The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer
Richard J Rebello, Eric Kusnadi, Donald P Cameron, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
May 21, 2021
Analysis of Myc Chromatin Binding by Calibrated ChIP-Seq Approach
Donald P Cameron, Vladislav Kuzin, Laura Baranello
STAR Protocols
|
August 9, 2022
TOP1 CAD-seq: A protocol to map catalytically engaged topoisomerase 1 in human cells
Vladislav Kuzin, Anika Wiegard, Donald P Cameron, et al.
Plos Genetics
|
September 9, 2021
Deficiency of Polη in Saccharomyces cerevisiae reveals the impact of transcription on damage-induced cohesion
Pei-Shang Wu, Jan Grosser, Donald P Cameron, et al.
Plos Pathogens
|
September 20, 2021
The Epstein-Barr virus deubiquitinating enzyme BPLF1 regulates the activity of topoisomerase II during productive infection
Jinlin Li, Noemi Nagy, Jiangnan Liu, et al.
Plos Neglected Tropical Diseases
|
March 7, 2017
Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis
Louise E Kerry, Elaine E Pegg, Donald P Cameron, et al.
Biomedicines
|
July 27, 2024
CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci
Donald P Cameron, Jirawas Sornkom, Sameerh Alsahafi, et al.
Frontiers in Cell and Developmental Biology
|
July 29, 2020
rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
Jinbae Son, Katherine M Hannan, Gretchen Poortinga, et al.
Molecular Cell
|
November 12, 2021
Topoisomerase 1 activity during mitotic transcription favors the transition from mitosis to G1
Anika Wiegard, Vladislav Kuzin, Donald P Cameron, et al.
Nature Communications
|
February 9, 2026
MYC modulates TOP2A diffusion to promote substrate detection and activity
Donald P Cameron, Kathryn Jackson, Alessia Loffreda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2016
The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer
Richard J Rebello, Eric Kusnadi, Donald P Cameron, et al.
Page
of 2